CYP 0.00% 24.5¢ cynata therapeutics limited

Ann: Appendix 4D & Half-Year Financial Statements, page-71

  1. 13,001 Posts.
    lightbulb Created with Sketch. 776
    viewph: "...but I don't think the board are capable of making commercial deals unfortunately."

    viewph/others: I do agree with "viewph" that the current CYP board seem NOT to be capable to make commercial deals. Eventually, they will have to improve in that respect (either by changing part of the board or alternatively by improving their management style/skills). Alternatively, in the end another company might make the necessary decision for them by taking CYP over - by that time potentially for very little money. Time will tell as usual.
    Comments by any of the few that are not on my ignore-list most welcome.

    wasa
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.